The underlying mechanism might be that there is a high level of IFN-γ in IBD intestinal tissue; IFN-γ can upregulate the expression of CD98 [9], which may induce Eos to express high levels of CD98. Here, SLC3A2 is linked to inflammatory bowel disease.